ATE185792T1 - Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE185792T1 ATE185792T1 AT96301517T AT96301517T ATE185792T1 AT E185792 T1 ATE185792 T1 AT E185792T1 AT 96301517 T AT96301517 T AT 96301517T AT 96301517 T AT96301517 T AT 96301517T AT E185792 T1 ATE185792 T1 AT E185792T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing same
- derivatives
- stilben derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PJANXHGTPQOBST-VAWYXSNFSA-N trans-stilbene Chemical class C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 title 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 125000002560 nitrile group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/33—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4758195 | 1995-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE185792T1 true ATE185792T1 (de) | 1999-11-15 |
Family
ID=12779227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96301517T ATE185792T1 (de) | 1995-03-07 | 1996-03-06 | Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5674906A (de) |
| EP (1) | EP0731085B1 (de) |
| KR (1) | KR100352048B1 (de) |
| CN (1) | CN1066713C (de) |
| AT (1) | ATE185792T1 (de) |
| CA (1) | CA2171275C (de) |
| DE (1) | DE69604714T2 (de) |
| DK (1) | DK0731085T3 (de) |
| ES (1) | ES2137628T3 (de) |
| GR (1) | GR3032311T3 (de) |
| PT (1) | PT731085E (de) |
| TW (1) | TW334418B (de) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999051246A1 (en) * | 1998-04-03 | 1999-10-14 | Ajinomoto Co., Inc. | Antitumor agents |
| US6624197B1 (en) | 1998-05-08 | 2003-09-23 | Calyx Therapeutics, Inc. | Diphenylethylene compounds |
| US6331633B1 (en) | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6245814B1 (en) | 1998-05-08 | 2001-06-12 | Calyx Therapeutics, Inc. | Diphenylethylene compounds |
| US7105552B2 (en) | 1998-05-08 | 2006-09-12 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US7407978B2 (en) * | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6849656B1 (en) * | 1999-09-17 | 2005-02-01 | Baylor University | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| US20020002200A1 (en) * | 2000-02-04 | 2002-01-03 | Bishwagit Nag | Novel diphenylethylene compounds |
| US20080108825A1 (en) * | 1999-11-08 | 2008-05-08 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
| US6525093B1 (en) | 1999-11-08 | 2003-02-25 | Calyx Therapeutics Inc. | Compounds to treat diabetes and associated conditions |
| US7323496B2 (en) * | 1999-11-08 | 2008-01-29 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
| US20080103302A1 (en) * | 2000-02-04 | 2008-05-01 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
| CA2407967C (en) | 2000-03-10 | 2010-10-05 | Baylor University | Tubulin binding ligands and corresponding prodrug constructs |
| SI1264821T1 (sl) * | 2000-03-17 | 2008-10-31 | Ajinomoto Kk | Nov kristal stilbenskega derivata in postopek za njegovo pripravo |
| US6670344B2 (en) | 2000-09-14 | 2003-12-30 | Bristol-Myers Squibb Company | Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts |
| US20050153939A1 (en) | 2003-09-10 | 2005-07-14 | Bristol-Myers Squibb Company | Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| AU1602902A (en) | 2000-10-27 | 2002-05-06 | Aventis Pharma Sa | A combination comprising camptothecin and a stilbene derivative for the treatment of cancer |
| US20020183266A1 (en) * | 2001-03-15 | 2002-12-05 | Aventis Pharma, S.A. | Combination comprising combretastatin and anticancer agents |
| PT1407784E (pt) * | 2001-06-25 | 2011-03-03 | Ajinomoto Kk | Agentes antitumorais |
| JPWO2003041740A1 (ja) * | 2001-11-16 | 2005-03-03 | 味の素株式会社 | 腫瘍壊死剤 |
| US6759555B2 (en) * | 2002-04-11 | 2004-07-06 | Aventis Pharma S.A. | Process for the preparation of combretastatins |
| FR2838437B1 (fr) * | 2002-04-11 | 2004-06-04 | Aventis Pharma Sa | Procedes de preparation de combretastatines |
| US20040063502A1 (en) * | 2002-09-24 | 2004-04-01 | Intec, Inc. | Power module |
| US20040224768A1 (en) * | 2002-09-24 | 2004-11-11 | Saied Hussaini | Video game controller with integrated status indicators |
| EP1591117A4 (de) | 2003-02-04 | 2006-04-26 | Yakult Honsha Kk | Bcrp (breast cancer resistance protein) inhibitor |
| EP1601348A4 (de) * | 2003-02-28 | 2008-12-10 | Oxigene Inc | Zusammensetzungen und verfahren mit verbesserter therapeutischer aktivität |
| GB2403949A (en) | 2003-07-18 | 2005-01-19 | Sigma Tau Ind Farmaceuti | Combretastatin derivatives |
| MX2007009888A (es) * | 2005-02-17 | 2007-10-16 | Synta Pharmaceuticals Corp | Compuestos para el tratamiento de trastornos proliferativos. |
| CN1301246C (zh) * | 2005-04-20 | 2007-02-21 | 江苏省原子医学研究所 | 1－氰基－1－(3,5－二甲氧基苯基)－2－(4－r基苯基)乙烯及其制备方法 |
| EP1746087A1 (de) | 2005-07-21 | 2007-01-24 | Universitaet Regensburg | 3-Indolylmethylen-Derivate mit cytostatischer Wirkung |
| FR2895258B1 (fr) * | 2005-12-22 | 2008-03-21 | Aventis Pharma Sa | Combinaison comprenant de la combretastatine et des agents anticancereux |
| CN101139358B (zh) * | 2006-09-07 | 2011-10-12 | 浙江大德药业集团有限公司 | 乙氧基康普立停及其前药的制备和用途 |
| CA2681850C (en) | 2007-04-20 | 2013-07-23 | Acucela Inc. | Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| WO2009067706A1 (en) | 2007-11-21 | 2009-05-28 | Oxigene, Inc. | Method for treating hematopoietic neoplasms |
| FR2928148B1 (fr) * | 2008-02-28 | 2013-01-18 | Sanofi Aventis | Procede de preparation de combretastatine |
| FR2945210B1 (fr) | 2009-05-07 | 2011-07-01 | Sanofi Aventis | Combinaison antitumorale comprenant l'ave8062 et le sorafenib |
| FR2953518B1 (fr) * | 2009-12-03 | 2012-01-20 | Sanofi Aventis | Procede de preparation d'un derive de combretastatine |
| EP2576514A1 (de) | 2010-06-04 | 2013-04-10 | Exonhit Sa | Substituierte isochinoline und deren verwendung als tubulinpolymerisationsinhibitoren |
| EP2397135A1 (de) | 2010-06-18 | 2011-12-21 | Sanofi | Antineoplastische Kombination, die Ombrabulin, ein Taxanderivat und ein Platinderivat umfasst |
| EP2481404A1 (de) | 2010-11-15 | 2012-08-01 | Sanofi | Antineoplastische Kombination, die Ombrabulin, ein Taxanderivat und ein Platinderivat umfasst |
| BR112012031917A2 (pt) | 2010-06-18 | 2017-11-28 | Sanofi Sa | combinação antitumoral compreendendo ombrabulina, um derivado de taxano e um derivado de platina |
| EP2407161A1 (de) | 2010-07-13 | 2012-01-18 | Sanofi | Antitumor-Kombination mit Ombrabulin und Bevacizumab |
| FR2968557A1 (fr) | 2010-12-09 | 2012-06-15 | Sanofi Aventis | Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab |
| CN110015962B (zh) | 2011-01-28 | 2022-03-15 | 肯塔基大学研究基金会 | 茋类似物和治疗癌症的方法 |
| CN102863388B (zh) | 2011-07-05 | 2015-04-29 | 南京圣和药业股份有限公司 | 肿瘤靶向药物Combretastatin A4衍生物 |
| WO2013084150A1 (en) * | 2011-12-06 | 2013-06-13 | Sanofi | Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof |
| WO2014089177A2 (en) | 2012-12-04 | 2014-06-12 | Massachusetts Institute Of Technology | Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines |
| CN103012248B (zh) * | 2013-01-11 | 2014-11-05 | 浙江大德药业集团有限公司 | 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用 |
| EP2972394A4 (de) | 2013-03-15 | 2016-11-02 | Sloan Kettering Inst Cancer | Hsp90-anzielende herzbildgebung und -therapie |
| EP3184095A1 (de) | 2013-05-23 | 2017-06-28 | IP Gesellschaft für Management mbH | Verabreichungseinheiten die ein polymorph 1 von 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide beinhalten |
| US9458086B1 (en) | 2013-07-03 | 2016-10-04 | University Of South Florida (A Florida Non-Profit Corporation) | Compositions and methods for adipocyte modulation |
| WO2015117147A1 (en) | 2014-02-03 | 2015-08-06 | Quadriga Biosciences, Inc. | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents |
| BR112016017993A2 (pt) | 2014-02-03 | 2017-08-08 | Quadriga Biosciences Inc | Gama-aminoácidos beta-substituídos e análogos como agentes quimioterapêuticos |
| US9487482B2 (en) * | 2014-05-09 | 2016-11-08 | Council Of Scientific And Industrial Research | 3,4,5-trimethoxystyrylarylaminopropenones as potential anticancer agents |
| KR20180035894A (ko) | 2015-08-03 | 2018-04-06 | 콰드리가 바이오사이언시스 인코포레이티드 | 화학치료제로서의 베타-치환된 베타-아미노산 및 유사체 및 이들의 용도 |
| US11419934B2 (en) | 2015-08-18 | 2022-08-23 | Oncotelic Therapeutics, Inc. | Use of VDAS to enhance immunomodulating therapies against tumors |
| WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
| US11932650B2 (en) | 2017-05-11 | 2024-03-19 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
| US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
| US11535634B2 (en) | 2019-06-05 | 2022-12-27 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
| CN112225673B (zh) * | 2020-11-13 | 2022-08-02 | 义乌市华耀医药科技有限公司 | 氨基康普立停衍生物及其应用 |
| WO2022182415A1 (en) | 2021-02-24 | 2022-09-01 | Massachusetts Institute Of Technology | Himastatin derivatives, and processes of preparation thereof, and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE589373A (de) * | 1959-04-08 | |||
| GB9106177D0 (en) | 1991-03-22 | 1991-05-08 | Aston Molecules Ltd | Substituted diphenylethylenes and analogues or derivatives thereof |
| AU4385293A (en) | 1992-05-21 | 1993-12-13 | Research Corporation Technologies, Inc. | Stilbene derivatives as anticancer agents |
| JP3180127B2 (ja) * | 1993-03-10 | 2001-06-25 | 森永乳業株式会社 | スチルベン誘導体とスチルベン同族体誘導体及びそれらの用途 |
| TW325458B (en) * | 1993-09-08 | 1998-01-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer |
-
1996
- 1996-03-05 TW TW085102704A patent/TW334418B/zh not_active IP Right Cessation
- 1996-03-06 PT PT96301517T patent/PT731085E/pt unknown
- 1996-03-06 DK DK96301517T patent/DK0731085T3/da active
- 1996-03-06 DE DE69604714T patent/DE69604714T2/de not_active Expired - Lifetime
- 1996-03-06 EP EP96301517A patent/EP0731085B1/de not_active Expired - Lifetime
- 1996-03-06 ES ES96301517T patent/ES2137628T3/es not_active Expired - Lifetime
- 1996-03-06 AT AT96301517T patent/ATE185792T1/de active
- 1996-03-07 CN CN96107344A patent/CN1066713C/zh not_active Expired - Lifetime
- 1996-03-07 CA CA002171275A patent/CA2171275C/en not_active Expired - Lifetime
- 1996-03-07 US US08/612,416 patent/US5674906A/en not_active Expired - Lifetime
- 1996-03-07 KR KR1019960005884A patent/KR100352048B1/ko not_active Expired - Lifetime
-
2000
- 2000-01-04 GR GR20000400011T patent/GR3032311T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0731085T3 (da) | 2000-04-17 |
| PT731085E (pt) | 2000-04-28 |
| EP0731085A1 (de) | 1996-09-11 |
| US5674906A (en) | 1997-10-07 |
| TW334418B (en) | 1998-06-21 |
| DE69604714D1 (de) | 1999-11-25 |
| GR3032311T3 (en) | 2000-04-27 |
| CN1066713C (zh) | 2001-06-06 |
| CA2171275C (en) | 2005-12-20 |
| CN1143629A (zh) | 1997-02-26 |
| EP0731085B1 (de) | 1999-10-20 |
| DE69604714T2 (de) | 2000-06-15 |
| KR100352048B1 (ko) | 2003-05-12 |
| KR960034164A (ko) | 1996-10-22 |
| CA2171275A1 (en) | 1996-09-08 |
| ES2137628T3 (es) | 1999-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE185792T1 (de) | Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE174899T1 (de) | Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE223378T1 (de) | Prolineamid-derivate | |
| YU11997A (sh) | Laktamski derivati i njihove farmaceutske kompozicije | |
| TR200003478T2 (tr) | Antikanser maddeleri olarak faydalı izotiyazol türevleri | |
| ATE226574T1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
| DE69218977D1 (de) | Trifluoromethylketon-Tripeptidderivate | |
| ATE321543T1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
| BR9608502A (pt) | Derivado da pirrola e composição medicinal | |
| BR9807330A (pt) | Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| ATE86117T1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| FI895139A0 (fi) | Pyrrolidinderivat. | |
| ATE147755T1 (de) | Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten | |
| ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| ES2091670T3 (es) | Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |